MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells

Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells

(2014) Chikato Koga et al.   ANNALS OF SURGICAL ONCOLOGY

Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer

(2014) V J Findlay et al.   CANCER GENE THERAPY

Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation

(2014) Kotaro Ohnishi et al.   CELL

Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

(2014) H. Takeyama et al.   MOLECULAR CANCER THERAPEUTICS

Hsa-miR-520d induces hepatoma cells to form normal liver tissues via a stemness-mediated process

(2014) Satoshi Tsuno et al.   Scientific Reports

Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor

(2013) Sharif Hossain et al.   PLoS One

The expanding role of miR-302–367 in pluripotency and reprogramming

(2012) Inna Lipchina et al.   CELL CYCLE

microRNAs in cancer management

(2012) Yi W Kong et al.   LANCET ONCOLOGY

Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming

(2012) X Zhang et al.   ONCOGENE

Novel Live Alkaline Phosphatase Substrate for Identification of Pluripotent Stem Cells

(2012) Upinder Singh et al.   Stem Cell Reviews and Reports

MicroRNA-302 Increases Reprogramming Efficiency via Repression of NR2F2

(2012) Shijun Hu et al.   STEM CELLS

Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency

(2011) Frederick Anokye-Danso et al.   Cell Stem Cell

Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs

(2011) Norikatsu Miyoshi et al.   Cell Stem Cell

MicroRNA Cluster 302–367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition

(2011) Baojian Liao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA miR-302 Inhibits the Tumorigenecity of Human Pluripotent Stem Cells by Coordinate Suppression of the CDK2 and CDK4/6 Cell Cycle Pathways

(2010) S.-L. Lin et al.   CANCER RESEARCH

The Promise of MicroRNA Replacement Therapy

(2010) A. G. Bader et al.   CANCER RESEARCH

Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes

(2010) Sharif Hossain et al.   JOURNAL OF CONTROLLED RELEASE

Regulation of somatic cell reprogramming through inducible mir-302 expression

(2010) Shi-Lung Lin et al.   NUCLEIC ACIDS RESEARCH

Defined factors induce reprogramming of gastrointestinal cancer cells

(2009) N. Miyoshi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation

(2008) Jing Wang et al.   NATURE GENETICS

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

(2008) S.-L. Lin et al.   RNA